|
|
|
|
Real-World Utilization of HIV Pre-Exposure Prophylaxis
(PrEP) by Cisgender and Transgender Individuals in the United States
|
|
|
Li Tao,1 Christoph Carter,1 Moupali Das,1 Jen Thorburn,2 Julie Paone,2 Amanda Kong,2 Chris Bush,2 Deesha Patel2
1Gilead Sciences, Inc., Foster City, California, USA; 2Aetion, Inc., New York, New York, USA
individuals not identified as TGM or TGW were classified as cisgender men (CGM) or women (CGW)
|
|
|
|
|
|
|